1. Market Research
  2. > Healthcare Market Trends
  3. > PGT Healthcare in Consumer Health (Israel)

PGT Healthcare in Consumer Health (Israel)

  • September 2016
  • -
  • Euromonitor International
  • -
  • 2 pages

PGT Healthcare plans to expand its portfolio of well-established brands and increase its presence in several categories. In particular, the company will expand its supplements product portfolio.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

PGT Healthcare in Consumer Health (Israel)
PGT HEALTHCARE IN CONSUMER HEALTH (ISRAEL)
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Strategic Direction
Key Facts
Summary 1 PGT Healthcare: Key Facts
Summary 2 PGT Healthcare: Operational Indicators
Competitive Positioning
Summary 3 PGT Healthcare: Competitive Position 2016












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Intercellular Adhesion Molecule 1 (Major Group Rhinovirus ...

Hepatitis A - Pipeline Review, H2 2016

Hepatitis A - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis A - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A – Pipeline Review, H2 2016, provides an overview of the ...

Irritable Bowel Syndrome - Pipeline Review, H2 2016

Irritable Bowel Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Irritable Bowel Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome – Pipeline Review, H2 2016, provides ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.